143 related articles for article (PubMed ID: 16277674)
21. Fibulin-2 and fibulin-5 alterations in tsk mice associated with disorganized hypodermal elastic fibers and skin tethering.
Lemaire R; Korn JH; Schiemann WP; Lafyatis R
J Invest Dermatol; 2004 Dec; 123(6):1063-9. PubMed ID: 15610515
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
23. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
24. Fibrillin 1 abnormalities in dermal fibroblast cultures from first-degree relatives of patients with systemic sclerosis (scleroderma).
Wallis DD; Tan FK; Kessler R; Kimball MD; Cretoiu JS; Arnett FC; Milewicz DM
Arthritis Rheum; 2004 Jan; 50(1):329-32. PubMed ID: 14730633
[No Abstract] [Full Text] [Related]
25. Fibulin-5 interacts with fibrillin-1 molecules and microfibrils.
Freeman LJ; Lomas A; Hodson N; Sherratt MJ; Mellody KT; Weiss AS; Shuttleworth A; Kielty CM
Biochem J; 2005 May; 388(Pt 1):1-5. PubMed ID: 15790312
[TBL] [Abstract][Full Text] [Related]
26. Immobilized metal affinity chromatography co-purifies TGF-β1 with histidine-tagged recombinant extracellular proteins.
Kaur J; Reinhardt DP
PLoS One; 2012; 7(10):e48629. PubMed ID: 23119075
[TBL] [Abstract][Full Text] [Related]
27. Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.
Gerber EE; Gallo EM; Fontana SC; Davis EC; Wigley FM; Huso DL; Dietz HC
Nature; 2013 Nov; 503(7474):126-30. PubMed ID: 24107997
[TBL] [Abstract][Full Text] [Related]
28. Anti-fibrillin-1 autoantibodies in normal pregnancy and recurrent pregnancy loss.
Atanasova MA; Konova EI; Aleksovska TA; Todorova KN; Georgieva MN; Lukanov TH
Autoimmun Rev; 2011 Jan; 10(3):131-6. PubMed ID: 20850568
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.
Seelig HP; Schröter H; Ehrfeld H; Renz M
J Immunol Methods; 1993 Oct; 165(2):241-52. PubMed ID: 8228274
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis.
Fritzler MJ; Hart DA; Wilson D; García-De La Torre I; Salazar-Páramo M; Vázquez-Del Mercado M; Senécal JL; Loyau S; Anglés-Cano E
J Rheumatol; 1995 Sep; 22(9):1688-93. PubMed ID: 8523346
[TBL] [Abstract][Full Text] [Related]
31. Is scleroderma an autoantibody mediated disease?
Arnett FC
Curr Opin Rheumatol; 2006 Nov; 18(6):579-81. PubMed ID: 17053501
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation.
Kissin EY; Lemaire R; Korn JH; Lafyatis R
Arthritis Rheum; 2002 Nov; 46(11):3000-9. PubMed ID: 12428243
[TBL] [Abstract][Full Text] [Related]
33. Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo.
Dallas SL; Keene DR; Bruder SP; Saharinen J; Sakai LY; Mundy GR; Bonewald LF
J Bone Miner Res; 2000 Jan; 15(1):68-81. PubMed ID: 10646116
[TBL] [Abstract][Full Text] [Related]
34. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
[TBL] [Abstract][Full Text] [Related]
35. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.
Endo H; Hosono T; Kondo H
J Rheumatol; 1994 May; 21(5):864-70. PubMed ID: 8064727
[TBL] [Abstract][Full Text] [Related]
36. Calcium determines the shape of fibrillin.
Reinhardt DP; Mechling DE; Boswell BA; Keene DR; Sakai LY; Bächinger HP
J Biol Chem; 1997 Mar; 272(11):7368-73. PubMed ID: 9054436
[TBL] [Abstract][Full Text] [Related]
37. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
[TBL] [Abstract][Full Text] [Related]
40. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
